Picture of Biotricity logo

BTCY — Biotricity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biotricity Inc reports results for the quarter ended in March - Earnings Summary

* Biotricity Inc  BTCY.OQ  reported a quarterly adjusted
loss of 9
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 9 cents per
share.
    * Revenue rose 27.5% to $2.74 million from a year ago;
analysts
expected $2.60 million. 
    * Biotricity Inc's reported EPS for the quarter was a loss
of 9
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Biotricity Inc shares had risen by 34.8% this quarter and
gained 39.9% so far this year.
    * The company reported a quarterly loss of $4.86 million.
    * Wall Street's median 12-month price target for Biotricity
Inc is
$2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data June
30 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.09          -0.09          Met
 Dec. 31 2022      -0.09          -0.09          Met
 Sep. 30 2022      -0.07          -0.09          Missed
 Jun. 30 2022      -0.11          -0.10          Beat

Recent news on Biotricity

See all news